Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal Cancer
Status:
Recruiting
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
This phase I/II study was designed to evaluate the efficacy and safety of fruquintinib
combination with capecitabine in maintenance treatment after first-line chemotherapy combined
with cetuximab.